Sponsor or institution

Clinical trials and research at Imunon

• 2Clinical trials
• 1Country

All recruiting trials (2)

• IMNN-001 combined with standard chemotherapy for newly diagnosed advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer

  This trial tests whether adding IMNN-001 (an intraperitoneal IL-12 plasmid therapy) to standard paclitaxel/carboplatin chemotherapy helps people with newly diagnosed advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.

  Recruiting at 10 sites Phase 3 Imunon · Orlando, Florida and 9 other locations · NCT06915025

• Adding IMNN-001 to chemotherapy for advanced ovarian cancer

  This study is testing if adding a new treatment called IMNN-001 to standard chemotherapy can help people with advanced ovarian cancer do better than with chemotherapy alone.

  Recruiting at 2 sites Phase 1/2 Imunon · Baltimore, Maryland and 3 other locations · NCT05739981

Quick answers

How many clinical trials run by Imunon are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →